HD-OPM Archive
Topics › Brain health & dementia

PREVENTABLE: 20,000-person trial of atorvastatin 40 mg to prevent dementia over age 75

Louis Nervegna · Oct 27, 2025 · ♥ 5 reactions · 1 comments · original Facebook post
Brain health & dementiaStatins
↻ This is a repost. The main version (highest ranked) is PREVENTABLE: 20,000-person trial of atorvastatin 40 mg to prevent dementia over age 75 · Jun 23, 2025.
AI summary & key facts

Louis describes the PREVENTABLE trial, a large randomized placebo-controlled study asking whether statins can prevent Alzheimer's and other dementias in people over 75. He explains the rationale: observational links between statin use and lower Alzheimer's rates plus mechanistic data implicating the mevalonate pathway, which statins target.

(no text — see the shared post below)

Research cited

The PREVENTABLE trial is a huge 20,000 person multicenter randomized controlled trial that aims to definitively answer the question:

Can statins prevent Alzheimer’s and other forms of dementia in healthy people over 75yo?

————-

The study began in 2020, and is still actively recruiting.

The intervention group will receive 40mg generic atorvastatin.

The control group will receive an identical placebo.

(The researchers purposely chose atorvastatin for this study because it is lipophilic and easily crosses the blood brain barrier.)

The full listing for the trial on clinicaltrials dot gov can be found here:

clinicaltrials.govClinicalTrials.govclinicaltrials.gov

The webpage for the trial is here:

preventabletrial.orgPREVENTABLEpreventabletrial.org

As we’ve spoken about many times in the group, there is a large amount of observational research that associates statin use with lower rates of Alzheimer’s. You can view some of those posts by searching the group for the tag #statinsdementiaHD.

There is also a lot of mechanistic data that suggests the pathogenesis of Alzheimer’s involves over-activation of the mevalonate pathway in the brain, which statins target. This is the same pathway by which cells synthesize cholesterol, among other things.

So a large trial like this in humans is long overdue.

This trial will finally answer the question of whether or not statins can prevent dementia.

Quoted from the clinical trials dot gov website:

“PREVENTABLE will randomly assign atorvastatin 40 mg daily or matching placebo daily to approximately 20,000 community-dwelling adults 75 years of age or older without clinically evident cardiovascular disease, significant disability, or dementia, and follow them for up to 5 years (estimated median of 3.8 years). The study will enroll participants from approximately 100 US sites.”

“Primary Outcome Measures: Number of patients without diagnosis of new dementia in each group (placebo vs. atorvastatin)
Time frame: 4 years”

#statinsHD #alzheimersHD #dementiaHD #statinsdementiaHD #ldldementiaHD #preventableHD #atorvastatinHD #statinselderlyHD

← newer: Generic atorvastatin costs about $7.70 per three months, so older: What CRP and hs-CRP actually measure, and why a single readi →